Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
FDA approved drug found to have anti-cancer activity against previously unknown targets

FDA approved drug found to have anti-cancer activity against previously unknown targets

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Study provides new insight into development of immune cells

Study provides new insight into development of immune cells

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Researchers identify new drug target for two common types of myeloid leukemia

Researchers identify new drug target for two common types of myeloid leukemia

Formaldehyde exposure not linked to leukemia, research shows

Formaldehyde exposure not linked to leukemia, research shows

Scientists launch new virtual platform to aid global search for treatment of leukemia

Scientists launch new virtual platform to aid global search for treatment of leukemia

Study identifies potential Achilles heel of kinase-driven cancers

Study identifies potential Achilles heel of kinase-driven cancers

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

High out-of-pocket costs may delay Medicare patients' access to novel targeted treatment for cancer

High out-of-pocket costs may delay Medicare patients' access to novel targeted treatment for cancer

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

Researchers develop new test for early detection of patients' resistance to leukemia treatment

Researchers develop new test for early detection of patients' resistance to leukemia treatment

Potential therapeutic approaches to combat chronic myeloid leukemia

Potential therapeutic approaches to combat chronic myeloid leukemia

RNA editing enzyme ADAR1 may play role in regeneration of leukemia stem cells

RNA editing enzyme ADAR1 may play role in regeneration of leukemia stem cells

High out-of-pocket costs linked to lower use of specialty drugs

High out-of-pocket costs linked to lower use of specialty drugs

Gleevec could be novel therapeutic agent for type 2 diabetes

Gleevec could be novel therapeutic agent for type 2 diabetes

New personalized DNA-based digital assay has potential to dramatically impact CML management

New personalized DNA-based digital assay has potential to dramatically impact CML management